scispace - formally typeset
A

Atbin Djamshidian

Researcher at Innsbruck Medical University

Publications -  108
Citations -  3230

Atbin Djamshidian is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Parkinson's disease & Medicine. The author has an hindex of 28, co-authored 91 publications receiving 2525 citations. Previous affiliations of Atbin Djamshidian include UCL Institute of Neurology & University of London.

Papers
More filters
Journal ArticleDOI

Exenatide and the treatment of patients with Parkinson’s disease

TL;DR: These results demonstrate a potential cost-efficient approach through which preliminary clinical data of possible biological effects are obtainable, prior to undertaking the major investment required for double-blind trials of a potential disease-modifying drug in PD.
Journal ArticleDOI

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours

TL;DR: The heightened response of striatal reward circuitry to heterogeneous reward-related visual cues among a group of patients with different impulsive-compulsive behaviours is consistent with a global sensitization to appetitive behaviours with dopaminergic therapy in vulnerable individuals.
Journal ArticleDOI

Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease

TL;DR: Patients previously exposed to exenatide had an advantage over the control group of patients, and this provides strong encouragement for the further study of this drug as a potential disease modifying agent in Parkinson's disease.
Journal ArticleDOI

Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis.

TL;DR: The study of the distribution of the pore-forming subunit of neuronal (N)-type voltage-gated calcium channels in the lesions of multiple sclerosis and EAE found that alpha(1B) was accumulated within axons and axonal spheroids of actively demyelinating lesions, suggesting that calcium influx through voltage-dependent calcium channels is one possible candidate mechanism for axonal degeneration in inflammatory demYelinating disorders.
Journal ArticleDOI

Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study.

TL;DR: In this article, the authors evaluated neurological signs and diseases by detailed neurological examination and a predefined test battery assessing smelling disorders (16-item Sniffin Sticks test), cognitive deficits (Montreal Cognitive Assessment), QoL (36-item Short Form), and mental health (Hospital Anxiety and Depression Scale, Posttraumatic Stress Disorder Checklist-5).